The STEP 1 trial showed Wegovy produced an average 14.9% body weight reduction over 68 weeks meaningful but achievable only for patients who can afford it or secure coverage
With the matched group on semaglutide, 28 reported gastroparesis.[ref][ref] Diabetic retinopathy: Two clinical trials in people with diabetes linked GLP-1 RA drugs to an increased risk of diabetic retinopathy, while other studies show that the drugs were not associated with the eye disease
Why are we keeping the solution in the fridge
However, it's important to note that the most common complaints focus on slower results, higher pricing, and occasional customer service issues
Important Safety Information What is the most important information I should know about Wegovy
If you have any questions on the scientific content of this article, please call a Life Extension Wellness Specialist at 1-866-864-3027